Patients with type 2 diabetes (T2D) at an elevated risk for kidney failure may stand to gain the most renal benefit with intensive glycemic control, but they also face the highest overall risk for ...

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Please provide your email address to receive an email when new articles are posted on . Using intensive blood pressure control in patients with stages 4 to 5 chronic kidney disease may delay the onset ...

Please provide your email address to receive an email when new articles are posted on . Tivozanib induced a significantly higher disease control rate than sorafenib among patients with relapsed or ...

Over 100 million Americans currently live with high blood pressure, yet many remain unaware of its profound connection to kidney health. This relationship represents one of medicine’s most critical ...

Editor’s note: The National Kidney Foundation sponsored a session on this topic at its 2012 Spring Clinical Meetings in National Harbor, Md. The moderators were George L. Bakris, MD, Professor of ...

Potassium and magnesium intake also have a role in hypertension management. Hypertension is no stranger to caregivers of patients with chronic kidney disease (CKD). Every health care provider working ...

PARIS, France—Two new renal denervation (RDN) systems seem to be safe and effective in patients with uncontrolled hypertension, according to presentations here at EuroPCR 2023. In the SMART trial, a ...

human kidneys, adrenal glands Intensive blood pressure control and fenofibrate use in patients with type 2 diabetes who are at high risk for cardiovascular disease may increase the risk for adverse ...